Advertisement

A chitosan film containing quercetin-loaded transfersomes for treatment of secondary osteoporosis

  • Ashlesha P. PanditEmail author
  • Sachin B. Omase
  • Vaishali M. Mute
Original Article
  • 16 Downloads

Abstract

Osteoporosis, due to its prevalence worldwide, is a serious health problem. Topical administration of quercetin, a phytoestrogen, in the form of deformable transfersomes, could be used to treat osteoporosis to overcome its low oral solubility and bioavailability. Formulation process of transfersomes was screened by fractional factorial design and further optimized using full factorial design. Transfersomes showed good characteristics such as entrapment efficiency, particle size, zeta potential, and polydispersity index (83.0 ± 2.2%, 75.95 ± 2 nm, − 13.6 ± 6 mv and 0.333, respectively). Transfersomes were further loaded into chitosan film and showed good permeation through rat skin. Further, glucocorticoid-induced osteoporosis rat model showed induction of osteoporosis after day 30. On day 45, treatment with chitosan film containing quercetin-loaded transfersomes showed remarkable rise in femur thickness, length, density as well as in serum biochemical parameters such as calcium, phosphorous, alkaline phosphatase, and tartrate-resistant alkaline phosphatase compared to positive control group. Tensile strength of osteoporotic femur bone was also found to be increased and was comparable with normal group. Histomicrographic analysis of femur bone exhibited less disruptive and lytic changes. Thus, all the above findings indicated the beneficial effects of quercetin-loaded transfersome chitosan film, due to decline in osteoclastogenesis and osteoblast apoptosis, which further favored increase in osteoblast numbers and mineralization of bones. Thus, chitosan film containing quercetin-loaded transfersomes was found to be good alternative to oral administration of quercetin to treat osteoporosis, while easy applicability of film in the form of wrist band anytime, anywhere, and even at work achieve patient compliance.

Graphical abstract

Keywords

Quercetin Transfersomes Glucocorticoid-induced osteoporosis Estrogenic receptors Phytoestrogen 

Notes

Acknowledgments

Authors thanked Mohini Organics Pvt. Ltd., India, for providing gift sample of Tween 80 as well as Vav Lipids Pvt. Ltd., India, for generously providing phosphatidylcholine. Authors also thanked Preclinical Research And Development Organization (PRADO) for performing and guiding us on histomorphometric analysis.

References

  1. 1.
    Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diebetes Endocrinol. 2017;11:898–907.  https://doi.org/10.1016/S2213-8587(17)30188-2.CrossRefGoogle Scholar
  2. 2.
    Shirwaikar A, Khan S, Malini S. Antiosteoporotic effect of ethanol extract of Cissus quadrangularis Linn. on ovariectomized rat. J Ethnopharmacol. 2003;89:245–50.CrossRefGoogle Scholar
  3. 3.
    Briot K. Bone and glucocorticoids. Ann Endocrinol. 2018;79(3):115–8.  https://doi.org/10.1016/j.ando.2018.04.0160003-4266.CrossRefGoogle Scholar
  4. 4.
    Canalis E, Delany AM. Mechanism of glucocorticoid action in bone. Ann N Y Acad Sci. 2002;966:73–81.CrossRefGoogle Scholar
  5. 5.
    Briot K, Roux C. Glucocorticoid-induced osteoporosis. RMD Open. 2015;1(1):e000014.  https://doi.org/10.1136/rmdopen-2014-000014.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Derakhshanian H, Djalali M, Djazayery A, Nourijelyani K, Ghadbeigi S, Pishva H, et al. Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate. Can J Physiol Pharmacol. 2013;91:380–5.  https://doi.org/10.1139/cjpp-2012-0190.CrossRefPubMedGoogle Scholar
  7. 7.
    Chen JS, Sambrook PN. Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol. 2012;8:81–91.  https://doi.org/10.1038/nrendo.2011.146.CrossRefGoogle Scholar
  8. 8.
    Haas AV, LeBoff MS. Osteoanabolic agents for osteoporosis. J Endocr Soc. 2018;2(8):922–32.CrossRefGoogle Scholar
  9. 9.
    Pandey MK, Gupta SC, Karelia D, Gilhooley PJ, Shakibaei M, Aggarwal BB. Dietary nutraceuticals as backbone for bone health. Biotechnol Adv. 2018;36(6):1633–48.  https://doi.org/10.1016/j.biotechadv.2018.03.014.CrossRefPubMedGoogle Scholar
  10. 10.
    Prouillet C, Mazière JC, Mazière C, Wattel A, Brazier M, Kamel S. Stimulatory effect of naturally occurring flavanols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol. 2004;67:1307–13.  https://doi.org/10.1016/j.bcp.2003.11.009.CrossRefPubMedGoogle Scholar
  11. 11.
    Wong RW, Rabie AB. Effect of quercetin on bone formation. J Orthop Res. 2008;26:1061–6.  https://doi.org/10.1002/jor.20638.CrossRefPubMedGoogle Scholar
  12. 12.
    Rai S, Pandey V, Rai G. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Rev Exp. 2017;8(1):1325708.  https://doi.org/10.1080/20022727.2017.1325708.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Bavarsad N, Kouchak M, Mohamadipour P, Sadeghi NB. Preparation and physicochemical characterization of topical chitosan-based film containing griseofulvin-loaded liposomes. J Adv Pharm Technol Res. 2016;7(3):91–8.  https://doi.org/10.4103/2231-4040.184591.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Zeb A, Qureshi OS, Kim HS, Cha JH, Kim HS, Kim JK. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomedicine. 2016;11:3813–24.CrossRefGoogle Scholar
  15. 15.
    Matucci-Cerinic M, Marabini S, Jantsch S, Cagnoni M, Partsch G. Effects of capsaicin on the metabolism of rheumatoid arthritis synoviocytes in vitro. Ann Rheum Dis. 1990;49(8):598–602.CrossRefGoogle Scholar
  16. 16.
    Souza AC, Goto GEO, Mainardi JA, Coelho ACV, Tadini CC. Cassava starch composite films incorporated with cinnamon essential oil: antimicrobial activity, microstructure, mechanical and barrier properties. LWT Food Sci Technol. 2013;54:346–52.CrossRefGoogle Scholar
  17. 17.
    Thakur R, Jain N, Pathak R, Sandhu SS. Practices in wound healing studies of plants. Evid Based Complement Altern Med. 2011;438056:1–17.  https://doi.org/10.1155/2011/438056.CrossRefGoogle Scholar
  18. 18.
    Aswar UM, Mohan V, Bodhankar SL. Antiosteoporotic activity of phytoestrogen-rich fraction separated from ethanol extract of aerial parts of Cissus quadrangularis in overiectomizedrats. Indian J Pharm. 2012;44:345–50.  https://doi.org/10.4103/0253-7613.96310.CrossRefGoogle Scholar
  19. 19.
    Potu BK, Rao MS, Nampurath GK, Chamallamudi MR, Prasad K, Nayak SR, et al. Evidence-based assessment of antiosteoporotic activity of petroleum-ether extract of Cissus quadrangularis Linn. on ovariectomy-induced osteoporosis. Ups J Med Sci. 2009;114:140–8.  https://doi.org/10.1080/03009730902891784.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Patricia B, Pedro C, Ana RM, Bruno S, Manuela P. Development and characterization of chitosan microparticles-in-films for buccal delivery of bioactive peptides. Pharm. 2019;12(32):1–15.  https://doi.org/10.3390/ph12010032.CrossRefGoogle Scholar
  21. 21.
    Ji JJ, Ding ZJ, Yang XL. Preparation and properties of chitosan film as a drug sustained-release system. Hua Xi Kou Qiang Yi Xue Za Zhi. 2009;27(3):248–51.PubMedGoogle Scholar
  22. 22.
    Han SB, Kwon SS, Jeong YM, Yu ER, Park SN. Physical characterization and in vitro skin permeation of solid lipid nanoparticles for transdermal delivery of quercetin. Int J Cosmet Sci. 2014;36(6):588–97.  https://doi.org/10.1111/ics.12160.CrossRefPubMedGoogle Scholar
  23. 23.
    Kajbafvala A, Salabat A, Salimi A. Formulation, characterization, and in-vitro/ex vivo evaluation of quercetin-loaded microemulsion for topical application. Pharm Dev Technol. 2018;23(8):741–50.  https://doi.org/10.1080/10837450.2016.1263995.CrossRefPubMedGoogle Scholar
  24. 24.
    Wang Y, Ohtsuka-Isoya M, Shao P, Sakamoto S, Shinoda H. Effects of methylprednisolone on bone formation and resorption in rats. Jpn J Pharmacol. 2002;90:236–46.CrossRefGoogle Scholar
  25. 25.
    Liu XY, Shi JH, Du WH, Fan YP, Hu XL, Zhang CC, et al. Glucocorticoids decrease body weight and food intake and inhibit appetite regulatory peptide expression in the hypothalamus of rats. Exp Ther Med. 2011;2(5):977–84.  https://doi.org/10.3892/etm.2011.292.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Liang W, Luo Z, Ge S, Li M, Du J, Yang M, et al. Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia. Eur J Pharmacol. 2011;670(1):317–24.  https://doi.org/10.1016/j.ejphar.2011.08.014.CrossRefPubMedGoogle Scholar
  27. 27.
    Ferreira A, Alho I, Casimiro S, Costa L. Bone remodeling markers and bone metastases: from cancer research to clinical implications. Bonekey Rep. 2015;4:668.  https://doi.org/10.1038/bonekey.2015.35.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Fink HA, Litwack-Harrison S, Taylor BC, Bauer DC, Orwoll ES, Lee CG, et al. Osteoporotic fractures in men (MROS) study group. Osteoporos Int. 2016;27(1):331–8.CrossRefGoogle Scholar
  29. 29.
    Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Väänänen HK. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res. 2000;15:1337–45.  https://doi.org/10.1359/jbmr.2000.15.7.1337.CrossRefPubMedGoogle Scholar
  30. 30.
    Zhao J, Li Y, Zhang H, Shi D, Li Q, Meng Y, et al. Preventive effects of metformin on glucocorticoid-induced osteoporosis in rats. J Bone Miner Metab. 2019;37:805–14.  https://doi.org/10.1007/s00774-019-00989-y.CrossRefPubMedGoogle Scholar
  31. 31.
    Masuhara M, Tsukahara T, Tomita K, Furukawa M, Miyawaki S, Sato T. A relation between osteoclastogenesis inhibition and membrane type estrogen receptor GPR30. Biochem Biophys Rep. 2016;8:389–94.  https://doi.org/10.1016/j.bbrep.2016.10.013.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    DBJ F, Pizziolo VR, Oliveira TT, Matta SLP, Píccolo MS, Queiroz JH. Biometric, histomorphometric, and biochemical profile in atorvastatin calcium treatment of female rats with dexamethasone-induced osteoporosis. Rev Bras Ortop. 2018;53(5):607–13.CrossRefGoogle Scholar
  33. 33.
    Sunita P, Pattanayak SP. Phytoestrogens in postmenopausal indications: a theoretical perspective. Pharmacogn Rev. 2011;5(9):41–7.  https://doi.org/10.4103/0973-7847.79098.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem. 2004;15(92):285–95.CrossRefGoogle Scholar
  35. 35.
    Yamaguchi M, Weitzmann MN. Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts. Int J Mol Med. 2011;28:521–5.  https://doi.org/10.3892/ijmm.2011.749.CrossRefPubMedGoogle Scholar
  36. 36.
    Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit JP, et al. Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol. 2003;65(1):35–42.CrossRefGoogle Scholar
  37. 37.
    Mohd Effendy N, Mohamed N, Muhammad N, Mohamad IN, Shuid AN. The effects of tualang honey on bone metabolism of postmenopausal women. Evid Based Complement Alternat Med. 2012;2012:938574.  https://doi.org/10.1155/2012/938574.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Rosales Rocabado JM, Kaku M, Nozaki K, Ida T, Kitami M, Aoyagi Y, et al. A multi-factorial analysis of bone morphology and fracture strength of rat femur in response to ovariectomy. J Orthop Surg Res. 2018;13(1):318.  https://doi.org/10.1186/s13018-018-1018-4.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Chavassieux P, Pastoureau P, Chapuy MC, Delmas PD, Meunier PJ. Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study. Osteoporos Int. 1993;3(2):97–102.CrossRefGoogle Scholar
  40. 40.
    Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61(1):7–16.  https://doi.org/10.1007/s12020-018-1588-2.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Xing LZ, Ni HJ, Wang YL. Quercetin attenuates osteoporosis in ovariectomized rats by regulating mitogen-activated protein kinase (MAPK) signaling pathways. Biomed Pharmacother. 2017;89:1136–41.  https://doi.org/10.1016/j.biopha.2017.02.073.CrossRefPubMedGoogle Scholar

Copyright information

© Controlled Release Society 2020

Authors and Affiliations

  • Ashlesha P. Pandit
    • 1
    Email author
  • Sachin B. Omase
    • 1
  • Vaishali M. Mute
    • 2
  1. 1.Department of PharmaceuticsJSPM’s Rajarshi Shahu College of Pharmacy and ResearchPuneIndia
  2. 2.Department of PharmacologyJSPM’s Rajarshi Shahu College of Pharmacy and ResearchPuneIndia

Personalised recommendations